Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis
ConclusionsBaseline noninvasive serum fibrosis and inflammation markers were significantly higher in patients developing a complication than in controls. During the follow-up only inflammatory markers decreased in controls, but not in cases, and thus could potentially be used to predict the occurrence of complications in cirrhotic patients.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Statistics | Study | Urology & Nephrology | Virology